Skip to content

Clinical trials

Observational Lipid Metabolism Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lipid Metabolism Disorders Phase: Observational Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20081
20091
20111
20131
20142
20152
20173
20184
20193
20205
20214
20224
20233
20244
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting9
Unknown status9
Active, not recruiting3
Terminated1
Withdrawn1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Colorado, Denver3
All India Institute of Medical Sciences, Bhubaneswar2
CENTOGENE GmbH Rostock2
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)2
Akrikhin1
Ankara Etlik City Hospital1
Boštjan Jakše1
Centre Hospitalier Universitaire de Saint Etienne1
China-Japan Friendship Hospital1
Chongqing Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lipid Metabolism Disorders44
Cardiovascular Diseases7
Atherosclerosis6
Obesity6
Dyslipidemias4
Lysosomal Storage Diseases4
Metabolic Diseases4
Coronary Artery Disease3
Genetic Diseases, Inborn3
Insulin Resistance3

Trials

Showing 51 to 44 of 44. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.